These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A statistical framework for genome-wide discovery of biomarker splice variations with GeneChip Human Exon 1.0 ST Arrays. Yoshida R; Numata K; Imoto S; Nagasaki M; Doi A; Ueno K; Miyano S Genome Inform; 2006; 17(1):88-99. PubMed ID: 17503359 [TBL] [Abstract][Full Text] [Related]
4. Libraries enriched for alternatively spliced exons reveal splicing patterns in melanocytes and melanomas. Watahiki A; Waki K; Hayatsu N; Shiraki T; Kondo S; Nakamura M; Sasaki D; Arakawa T; Kawai J; Harbers M; Hayashizaki Y; Carninci P Nat Methods; 2004 Dec; 1(3):233-9. PubMed ID: 15782199 [TBL] [Abstract][Full Text] [Related]
5. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. Gardina PJ; Clark TA; Shimada B; Staples MK; Yang Q; Veitch J; Schweitzer A; Awad T; Sugnet C; Dee S; Davies C; Williams A; Turpaz Y BMC Genomics; 2006 Dec; 7():325. PubMed ID: 17192196 [TBL] [Abstract][Full Text] [Related]
6. Changes in alternative splicing of human and mouse genes are accompanied by faster evolution of constitutive exons. Cusack BP; Wolfe KH Mol Biol Evol; 2005 Nov; 22(11):2198-208. PubMed ID: 16049198 [TBL] [Abstract][Full Text] [Related]
7. Evidence for the regulation of alternative splicing via complementary DNA sequence repeats. Lian Y; Garner HR Bioinformatics; 2005 Apr; 21(8):1358-64. PubMed ID: 15673565 [TBL] [Abstract][Full Text] [Related]
8. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer. Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715 [TBL] [Abstract][Full Text] [Related]
9. Genome-wide detection of testis- and testicular cancer-specific alternative splicing. He C; Zuo Z; Chen H; Zhang L; Zhou F; Cheng H; Zhou R Carcinogenesis; 2007 Dec; 28(12):2484-90. PubMed ID: 17724370 [TBL] [Abstract][Full Text] [Related]
10. Identification of a novel protein isoform derived from cancer-related splicing variants using combined analysis of transcriptome and proteome. Hatakeyama K; Ohshima K; Fukuda Y; Ogura S; Terashima M; Yamaguchi K; Mochizuki T Proteomics; 2011 Jun; 11(11):2275-82. PubMed ID: 21548097 [TBL] [Abstract][Full Text] [Related]
11. Computational analysis suggests that alternative first exons are involved in tissue-specific transcription in rice (Oryza sativa). Kitagawa N; Washio T; Kosugi S; Yamashita T; Higashi K; Yanagawa H; Higo K; Satoh K; Ohtomo Y; Sunako T; Murakami K; Matsubara K; Kawai J; Carninci P; Hayashizaki Y; Kikuchi S; Tomita M Bioinformatics; 2005 May; 21(9):1758-63. PubMed ID: 15647298 [TBL] [Abstract][Full Text] [Related]
12. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array. Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260 [TBL] [Abstract][Full Text] [Related]
13. Expression of alternative transcripts of ferroportin-1 during human erythroid differentiation. Cianetti L; Segnalini P; Calzolari A; Morsilli O; Felicetti F; Ramoni C; Gabbianelli M; Testa U; Sposi NM Haematologica; 2005 Dec; 90(12):1595-606. PubMed ID: 16330432 [TBL] [Abstract][Full Text] [Related]
14. Generation of interleukin-17 receptor-like protein (IL-17RL) in prostate by alternative splicing of RNA. Haudenschild DR; Curtiss SB; Moseley TA; Reddi AH Prostate; 2006 Sep; 66(12):1268-74. PubMed ID: 16688746 [TBL] [Abstract][Full Text] [Related]
15. Identification of human exons overexpressed in tumors through the use of genome and expressed sequence data. Kirschbaum-Slager N; Parmigiani RB; Camargo AA; de Souza SJ Physiol Genomics; 2005 May; 21(3):423-32. PubMed ID: 15784694 [TBL] [Abstract][Full Text] [Related]
16. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Panzitt K; Tschernatsch MM; Guelly C; Moustafa T; Stradner M; Strohmaier HM; Buck CR; Denk H; Schroeder R; Trauner M; Zatloukal K Gastroenterology; 2007 Jan; 132(1):330-42. PubMed ID: 17241883 [TBL] [Abstract][Full Text] [Related]
17. Identification of alternative splicing markers for breast cancer. Venables JP; Klinck R; Bramard A; Inkel L; Dufresne-Martin G; Koh C; Gervais-Bird J; Lapointe E; Froehlich U; Durand M; Gendron D; Brosseau JP; Thibault P; Lucier JF; Tremblay K; Prinos P; Wellinger RJ; Chabot B; Rancourt C; Elela SA Cancer Res; 2008 Nov; 68(22):9525-31. PubMed ID: 19010929 [TBL] [Abstract][Full Text] [Related]
18. Insights into the connection between cancer and alternative splicing. Kim E; Goren A; Ast G Trends Genet; 2008 Jan; 24(1):7-10. PubMed ID: 18054115 [TBL] [Abstract][Full Text] [Related]
19. Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript. De Rosa M; Morelli G; Cesaro E; Duraturo F; Turano M; Rossi GB; Delrio P; Izzo P Gene; 2007 Jun; 395(1-2):8-14. PubMed ID: 17360132 [TBL] [Abstract][Full Text] [Related]
20. Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues. Saebøe-Larssen S; Fossberg E; Gaudernack G BMC Mol Biol; 2006 Aug; 7():26. PubMed ID: 16939641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]